Citadel Advisors’s Galmed Pharmaceuticals GLMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-938
| Closed | -$5.12K | – | 6371 |
|
|
2023
Q4 | $5.12K | Sell |
938
-2,434
| -72% | -$13.3K | ﹤0.01% | 5608 |
|
|
2023
Q3 | $25.1K | Buy |
+3,372
| New | +$25.1K | ﹤0.01% | 5261 |
|
|
2023
Q2 | – | Sell |
-227
| Closed | -$17.4K | – | 6039 |
|
|
2023
Q1 | $17.4K | Buy |
+227
| New | +$17.4K | ﹤0.01% | 5420 |
|
|
2022
Q4 | – | Sell |
-103
| Closed | -$6K | – | 6296 |
|
|
2022
Q3 | $6K | Sell |
103
-228
| -69% | -$13.3K | ﹤0.01% | 5686 |
|
|
2022
Q2 | $41K | Buy |
331
+261
| +373% | +$32.3K | ﹤0.01% | 5560 |
|
|
2022
Q1 | $20K | Buy |
+70
| New | +$20K | ﹤0.01% | 6134 |
|
|
2021
Q4 | – | Sell |
-156
| Closed | -$78K | – | 6723 |
|
|
2021
Q3 | $78K | Sell |
156
-63
| -29% | -$31.5K | ﹤0.01% | 5976 |
|
|
2021
Q2 | $120K | Buy |
+219
| New | +$120K | ﹤0.01% | 5878 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 6456 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 4731 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 4667 |
|